Sign in
4

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0001732369-26-000002

Options or other derivatives

  • CHIEF EXECUTIVE OFFICER acquired 62,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Seehra Jasbir CHIEF EXECUTIVE OFFICER 2026-01-07 Grant or award · Employee Stock Option (right to buy) +62,500 62,500 D
Loading xslF345X05/form4-01092026_040101.xml…